EUVIMEDEUVIMED entdecken
Crossref

DLGAP3 suppresses malignant behaviors of glioma cells via inhibiting RGS12-mediated MAPK/ERK signaling

Jing Wei, Yuan Li, Fangzheng Jiao, Xiaoya Wang, Han Zhou, Yifan Qiao, Zihan Yuan, Chao Qian, Yanlong Tian, Yan Fang

Brain Research · 2025-02 · 1848 · 149334

DOI: 10.1016/j.brainres.2024.149334 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Research, 2025-02. Verfasst von Jing Wei und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medicine, Shaanxi University of Chinese Medicine, Xianyang 712046, China. Electronic address: wj361874220@sina.com. Hauptthemen laut MEDLINE: Glioma, MAP Kinase Signaling System, Brain Neoplasms, RGS Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Shaanxi Province Key Research and Development Projects, National Natural Science Foundation of China, Foundation for Innovative Research Groups of the National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Glioma is the most common malignant tumor of the central nervous system, and is characterized by high recurrence, poor prognosis and especially complex pathogenesis. The synaptic plasticity-related protein DLGAP3 is mainly involved in the assembly and function of postsynaptic density complex. It's widely known that DLGAP3 participating in the occurrence of various neuropsychiatric diseases, but its role in glioma tumorigenesis remains largely unclear. METHODS: We ectopically expressed and knocked down DLGAP3 in glioma cells to perform a series of functional studies in vitro. Meanwhile, western blot analysis, co-immunoprecipitation, enrichment analysis and dual-luciferase reporter system assays were performed to explore the mechanism of DLGAP3 suppressing glioma tumorigenesis and progression. RESULTS: We found that DLGAP3 was low expressed in gliomas, and decreased DLGAP3 expression was strongly correlated with poor survival of glioma patients. Ectopic expression of DLGAP3 in glioma cell lines dramatically inhibited cell proliferation, invasion and migration. In addition, our data also showed that DLGAP3 can tightly connected with RGS12, and DLGAP3 overexpression significantly increased the expression of RGS12 and inhibited the phosphorylation levels of MEK and ERK. Furthermore, the RGS12 inhibited transcription and translation of BRAF, which further decreased the activity of MAPK/ERK signaling pathway. This suggests that DLGAP3 may act as a tumor suppressor in gliomas and inhibits glioma tumorigenesis by regulating RGS12 and the downstream MAPK/ERK signals axis. CONCLUSION: Our data indicates that DLGAP3 is a potential tumor suppressor and valuable prognostic biomarker in gliomas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaMAP Kinase Signaling SystemBrain NeoplasmsRGS ProteinsCell ProliferationHumansCell Line, TumorCell MovementAnimalsMiceGTPase-Activating ProteinsMice, NudeGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

DLGAP3GliomaMAPK/ERK signaling pathwayRGS12

Substanzen

RGS ProteinsGTPase-Activating Proteins

Autor:innen und Institutionen

  • Department of Basic Medicine, Shaanxi University of Chinese Medicine, Xianyang 712046, China. Electronic address: wj361874220@sina.com.
  • Department of Basic Medicine, Shaanxi University of Chinese Medicine, Xianyang 712046, China.
  • Department of Clinical Medicine, Yan'an University School of Medicine, Yan'an 716000, China.
  • No.215 Hospital of Shaanxi Nuclear Industry, Xianyang 712000, China.

Förderung

  • Shaanxi Province Key Research and Development Projects
  • National Natural Science Foundation of China
  • Foundation for Innovative Research Groups of the National Natural Science Foundation of China
  • Shanghai University of Traditional Chinese Medicine

Zitieren

APA

Wei, J., Li, Y., Jiao, F., Wang, X., Zhou, H., Qiao, Y., Yuan, Z., Qian, C., Tian, Y., & Fang, Y. (2025). DLGAP3 suppresses malignant behaviors of glioma cells via inhibiting RGS12-mediated MAPK/ERK signaling. Brain Research, 1848, 149334. https://doi.org/10.1016/j.brainres.2024.149334

Vancouver

Wei J, Li Y, Jiao F, Wang X, Zhou H, Qiao Y, et al. DLGAP3 suppresses malignant behaviors of glioma cells via inhibiting RGS12-mediated MAPK/ERK signaling. Brain Research. 2025;1848:149334. doi:10.1016/j.brainres.2024.149334

BibTeX
@article{Wei2025,
  author = {Wei, Jing and Li, Yuan and Jiao, Fangzheng and Wang, Xiaoya and Zhou, Han and Qiao, Yifan and Yuan, Zihan and Qian, Chao and Tian, Yanlong and Fang, Yan},
  title = {DLGAP3 suppresses malignant behaviors of glioma cells via inhibiting RGS12-mediated MAPK/ERK signaling},
  journal = {Brain Research},
  year = {2025},
  volume = {1848},
  pages = {149334},
  doi = {10.1016/j.brainres.2024.149334}
}
Kostenlos starten →